MAP Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- MAP Pharmaceuticals's estimated annual revenue is currently $28.5M per year.
- MAP Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- MAP Pharmaceuticals has 142 Employees.
- MAP Pharmaceuticals grew their employee count by -1% last year.
MAP Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
MAP Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is MAP Pharmaceuticals?
MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEXâ„¢ inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.
keywords:N/A
N/A
Total Funding
142
Number of Employees
$28.5M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MAP Pharmaceuticals News
Prior to MyoKardia, his extensive experience included leadership roles at MAP Pharmaceuticals (acquired by Allergan), Codexis Inc. and...
The company is working to generate extensive data that will help map out the links between drug candidates, genetics and biochemical...
The Resilient Drug Supply Map will be a tool for stakeholders, policymakers, and consumers as they work to ensure that prescription drugs are...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $22.1M | 142 | -21% | $66M |
#2 | $20.3M | 142 | -1% | N/A |
#3 | $51.5M | 142 | 7% | N/A |
#4 | $45.3M | 142 | 4% | N/A |
#5 | $23.4M | 142 | 10% | N/A |